Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy
Keywords: مهار کننده های بازرسی; Anti-PD-1; Side-effect; Toxicity; Pembrolizumab; Nivolumab; Checkpoint inhibitors; Tolerability; Immune-related; Adverse event;